At the end of a clinical trial, or when products reach their expiry date at site level, investigational materials are returned to our facility for controlled processing.
Our dedicated teams manage the complete returns workflow to ensure full accountability, regulatory compliance and accurate inventory reconciliation.
Upon receipt, all returned products are thoroughly inspected and documented.
Verification activities include:
A comprehensive reconciliation process is performed to confirm the accountability of all clinical trial supplies throughout the study.
This involves comparing:
Any discrepancy identified during reconciliation is investigated through a documented process to determine the root cause and ensure complete product accountability.
All returned materials are placed in a dedicated quarantine area, physically separated from active and released inventory to prevent any risk of mix-up or unintended reuse.
Our robust returns and reconciliation procedures provide sponsors with full visibility of product accountability while supporting regulatory compliance and audit readiness throughout the clinical trial lifecycle.
This controlled segregation ensures:
Following completion of the reconciliation process and sponsor approval, returned or obsolete or expired clinical trial materials are removed from inventory and destroyed through qualified waste management partners.
We coordinate the entire destruction process to ensure compliance with regulatory, environmental and study-specific requirements.
Our services include:
Full traceability is maintained throughout the destruction process, providing sponsors with complete visibility and audit-ready records.
By managing product destruction through an established network of qualified partners, we ensure the secure, compliant and fully documented disposition of clinical trial materials at the end of their lifecycle.
Documentation includes: